2010 NEWS RELEASES
August 19, 2010HUMAN GENOME SCIENCES AND GLAXOSMITHKLINE ANNOUNCE FDA PRIORITY REVIEW DESIGNATION FOR BENLYSTA® (BELIMUMAB) AS A POTENTIAL TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS
August 13, 2010HUMAN GENOME SCIENCES NAMES TUOMO PÄTSI VICE PRESIDENT, HGS EUROPE
July 22, 2010HUMAN GENOME SCIENCES ANNOUNCES SECOND QUARTER 2010 FINANCIAL RESULTS AND KEY DEVELOPMENTS
July 13, 2010HUMAN GENOME SCIENCES AND LONZA ENTER COMMERCIAL MANUFACTURING AGREEMENT FOR BENLYSTA®, A POTENTIAL NEW TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS
June 25, 2010HUMAN GENOME SCIENCES ANNOUNCES PRESENTATION OF ADDITIONAL PHASE 3 SLE STUDY RESULTS FOR BENLYSTA® (BELIMUMAB) AT INTERNATIONAL CONGRESS ON SLE
June 21, 2010HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT NASDAQ OMX 24th INVESTOR PROGRAM
June 17, 2010HUMAN GENOME SCIENCES AND GLAXOSMITHKLINE ANNOUNCE FULL PRESENTATION AT EULAR OF BLISS-76 PHASE 3 STUDY RESULTS FOR BENLYSTA® IN SYSTEMIC LUPUS ERYTHEMATOSUS
June 17, 2010HUMAN GENOME SCIENCES AND GLAXOSMITHKLINE ANNOUNCE PRESENTATION AT EULAR OF BLISS-52 PHASE 3 SLE STUDY RESULTS FOR BENLYSTA® (BELIMUMAB)
June 14, 2010HUMAN GENOME SCIENCES ANNOUNCES PRELIMINARY FEEDBACK FROM FDA ON ZALBIN™ BLA FOR CHRONIC HEPATITIS C
June 11, 2010HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT GOLDMAN SACHS HEALTHCARE CONFERENCE
June 10, 2010HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT ANALYST & INVESTOR MEETING
June 10, 2010HUMAN GENOME SCIENCES ANNOUNCES SUBMISSION OF BIOLOGICS LICENSE APPLICATION TO FDA FOR BENLYSTA® (BELIMUMAB)
June 9, 2010HUMAN GENOME SCIENCES ANNOUNCES RESULTS OF RANDOMIZED PHASE 2 TRIAL OF MAPATUMUMAB IN MULTIPLE MYELOMA
June 7, 2010HUMAN GENOME SCIENCES ANNOUNCES SUBMISSION OF MARKETING AUTHORIZATION APPLICATION TO EMA FOR BENLYSTA® (BELIMUMAB)
May 24, 2010HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT CITI HEALTH CARE CONFERENCE
May 7, 2010HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BANK OF AMERICA MERRILL LYNCH HEALTH CARE CONFERENCE
April 29, 2010HUMAN GENOME SCIENCES ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS AND KEY DEVELOPMENTS
April 29, 2010HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT DEUTSCHE BANK HEALTH CARE CONFERENCE
April 20, 2010HUMAN GENOME SCIENCES AND GLAXOSMITHKLINE ANNOUNCE TOPLINE 76-WEEK RESULTS OF PHASE 3 TRIAL OF BENLYSTA™ IN SYSTEMIC LUPUS ERYTHEMATOSUS
April 19, 2010HUMAN GENOME SCIENCES ANNOUNCES WITHDRAWAL OF EUROPEAN MARKETING AUTHORIZATION APPLICATION FOR JOULFERON® (ZALBIN™) FOR THE TREATMENT OF CHRONIC HEPATITIS C
March 24, 2010HUMAN GENOME SCIENCES ANNOUNCES INTERIM RESULTS OF PHASE 2B MONTHLY-DOSING TRIAL OF ZALBIN™ IN PATIENTS WITH CHRONIC HEPATITIS C
March 19, 2010HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT THE BARCLAYS CAPITAL HEALTHCARE CONFERENCE
March 17, 2010HUMAN GENOME SCIENCES ANNOUNCES RESULTS OF RANDOMIZED PHASE 2 TRIAL OF MAPATUMUMAB IN NON-SMALL CELL LUNG CANCER
March 11, 2010HUMAN GENOME SCIENCES AND BIOINVENT ANNOUNCE COLLABORATION TO CO-DEVELOP AND COMMERCIALIZE THERAPEUTIC ANTIBODIES
March 9, 2010HUMAN GENOME SCIENCES APPOINTS DAVID P. SOUTHWELL EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
March 5, 2010HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT THE COWEN AND COMPANY HEALTH CARE CONFERENCE
March 2, 2010HUMAN GENOME SCIENCES ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2009 FINANCIAL RESULTS AND KEY DEVELOPMENTS
March 1, 2010HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT RBC CAPITAL MARKETS HEALTHCARE CONFERENCE
February 5, 2010HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BIO CEO INVESTOR CONFERENCE
February 1, 2010HUMAN GENOME SCIENCES NAMES SCOTT HABIG VICE PRESIDENT, SALES
January 11, 2010HUMAN GENOME SCIENCES REPORTS INCREASING MOMENTUM TOWARD COMMERCIALIZATION AND ANNOUNCES 2010 GOALS AT JPMORGAN HEALTHCARE CONFERENCE
January 6, 2010HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT JPMORGAN CONFERENCE
